SEC Form 4 · accession 0001209191-15-058813
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip D Gregory
Officer — Chief Scientific Officer
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $163.07 | Jul 1, 2015 | A | 50,000 | A | — | Jul 1, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1This option vests over a four-year period, at a rate of twenty-five percent (25%) on June 15, 2016 and in 36 equal monthly installments thereafter.